NCT05987579Active, not recruiting
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
Source: ClinicalTrials.gov · Last updated 4 Apr 2025
Brief summary (registry, in English)
This study examines tumor- en surgical characteristics of stage T3 cutaneous squamous cell carcinomas on the scalp, diagnosed between 2010 and 2018. Histological data and patient- and tumor characteristics were collected.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 104 (actual)
- First submitted
- 20 Jul 2023
- Start date
- 3 May 2021
- Primary completion date
- 1 Sept 2024
- Lead sponsor
- Maastricht University Medical Center
- NCT number
- NCT05987579
What you commit to
- Study type: Observational
- Participants enrolled: 104
- From 3 May 2021 to the primary completion date, 1 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- metastasis by diagnosis
- stage T1/T2/T4
Who the study is looking for
- stage T3 cutaneous squamous cell carcinoma of the scalp (histologically proven)
- surgical treatment or radiotherapy treatment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ellen Oyen Coordinator of this site? Confirm its status | Maastricht | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.